Search - tctmd.com

Displaying 1 - 20 of 452

Sort: Relevancy | Date

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Features

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Shelley Wood

December 30, 2016

News Daily News

TAVR: Miracle for Some, but No Improvements in Quality of Life for Others

Yael L. Maxwell

December 22, 2016

News Daily News

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Michael O'Riordan

December 19, 2016

News Conference News AHA 2016

Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement

Shelley Wood

November 14, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Shelley Wood

November 07, 2016

News Conference News TCT 2016

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Todd Neale

November 02, 2016

Presentation TCT 2016

Pousser La Limite Du TAVI Transfemoral En Toute Prudence/How to Push the TF-TAVR Limit Safely!

Presenter: Bernard R. Chevalier, Philippe Généreux, Eric Van Belle

November 01, 2016

Presentation TCT 2016

Transfemoral Large Hole Closure Devices: Manta, Inseal, and Others

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Alexandre Abizaid

November 01, 2016

News Conference News TCT 2016

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Todd Neale

November 01, 2016

News Industry News TCT 2016

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

November 01, 2016

Presentation TCT 2016

Complications 2. How to Prevent and Treat Transfemoral Access Site Complications

Presenter: Neil E. Moat, John G. Webb, Stephen R. Ramee

October 31, 2016

Presentation TCT 2016

Germany Presents: How Did I Treat This Case

Presenter: Dariusz Dudek, Petr Kala, Michael Haude

October 30, 2016

Presentation TCT 2016

Czech Republic Responds: How Would I Treat This Case?

Presenter: Dariusz Dudek, Petr Kala, Martin Mates

October 30, 2016

Presentation TCT 2016

Germany Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Presenter: Dariusz Dudek, Petr Kala, Michael Haude

October 30, 2016

Presentation TCT 2016

Poland Presents: How Did I Treat This Case?

Presenter: Dariusz Dudek, Petr Kala, Andrzej J. Ochala

October 30, 2016

Presentation TCT 2016

France Responds: How Would I Treat This Case?

Presenter: Dariusz Dudek, Petr Kala, Patrick Ohlmann

October 30, 2016

Presentation TCT 2016

Poland Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Presenter: Dariusz Dudek, Petr Kala, Andrzej J. Ochala

October 30, 2016

Presentation TCT 2016

Germany Presents: Treatment Options - Should Severe Mitral Regurgitation be Treated Prior, During or After TAVR (and in a Single or Staged Procedures)?

Presenter: Dariusz Dudek, Petr Kala, Holger Thiele

October 30, 2016

Advertisement

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

TAVR: Miracle for Some, but No Improvements in Quality of Life for Others

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Pousser La Limite Du TAVI Transfemoral En Toute Prudence/How to Push the TF-TAVR Limit Safely!

Transfemoral Large Hole Closure Devices: Manta, Inseal, and Others

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

Complications 2. How to Prevent and Treat Transfemoral Access Site Complications

Germany Presents: How Did I Treat This Case

Czech Republic Responds: How Would I Treat This Case?

Germany Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Poland Presents: How Did I Treat This Case?

France Responds: How Would I Treat This Case?

Poland Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Germany Presents: Treatment Options - Should Severe Mitral Regurgitation be Treated Prior, During or After TAVR (and in a Single or Staged Procedures)?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content